The developmental genetics of congenital heart disease
By B. Bruneau. Nature, 2008
819 citations recorded by the source corpus.
Subfields: Epidemiology, Molecular Biology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/ae47a973615a808c8718e4fabea307ce9fc44f07
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Molecular Biology
- Jormay Lim
- E. Olson
- E. Small
- J. P. Thiery
- C. Burge
- Laurie A. Boyer
- Robert K. Bradley
- David P. Bartel
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Dynamic and Coordinated Epigenetic Regulation of Developmental Transitions in the Cardiac Lineage (2012, neutral): “Many of these genes have important roles in heart development and their dysregulation is associated with heart defects and cardiovascular disease (Bruneau, 2008; Srivastava, 2006).”
- Epithelial-mesenchymal transitions: insights from development (2012, background): “Zeb1 and Zeb2 are also targeted by the miR-200 family (Christoffersen et al., 2007; Burk et al., 2008; Gregory et al., 2008; Korpal et al., 2008), which is regulated by the ratio of the levels of Akt1 to Akt2 (Iliopoulos et al., 2009).”
- Braveheart, a long non-coding RNA required for cardiovascular lineage commitment (2013, background): “of gene expression patterns, and disruption of transcriptional networks that govern cardiac commitment underlies congenital heart disease (CHD) (Bruneau, 2008; Srivastava, 2006).”
- Transcriptional Regulation and its Misregulation in Disease (2013, neutral): “…Disease Misregulated development of the cardiovascular system is among the most common class of congenital birth defects and diseases of the cardiovascular system are among the most prevalent clinical issues for adult populations (Bruneau, 2008; Kathiresan and Srivastava, 2012; Roger et al., 2012).”
- Pervasive roles of microRNAs in cardiovascular biology (2011, background): “16), the phosphatidylinositol-3-OH kinase (PI(3)K)–AKT pathway by miR-486 (ref.”